US Medical Bill Shock for Indian Senior Citizen: $283 Consultation, $513 Medicines, Made in India
An Indian senior citizen's experience with the US healthcare system has gone viral on social media, sparking debate on the affordability of medical treatment in India compared to the United States.
In a post on X (formerly Twitter), user Adhir Sinha narrated the ordeal of an elderly couple from India who had been staying in Seattle for two months. The couple ran out of medicines they had brought from India, which were prescribed for the wife's respiratory illness. Needing a fresh prescription, they sought medical help locally.
The cost was a shock. The doctor's consultation fee alone was $283 (approximately Rs 23,000). The prescribed medicines added another $513 (around Rs 42,000), bringing the total to over Rs 65,000. Moreover, the medicines were not immediately available; it took four to five days to arrive at the pharmacy. When they finally collected them, they were surprised to find that the medications were manufactured by Indian pharmaceutical company Cipla and labelled 'Made in India'.
The senior citizen reflected on the contrast: 'It took us 12 days to obtain medicines here that are readily available at any pharmacy in India.' He advised others to consider themselves fortunate to be living in India during retirement years, praising India's affordable healthcare, inexpensive mobile data, rapid grocery delivery, easy access to specialists, doorstep diagnostics, UPI payments, available domestic help, and community spirit.
The post has ignited widespread discussion. Many users agreed that India's healthcare is more affordable and accessible for routine care. Others emphasised the necessity of medical insurance in the US, where consultation fees, lab tests, and prescriptions are often billed separately, leading to high out-of-pocket costs.
However, some users pointed out a more nuanced picture. The US healthcare system offers advanced treatments, cutting-edge technology, and specialised care, which contribute to its higher costs. The comparison between the two systems is not always straightforward, and factors such as income levels, insurance coverage, and the nature of medical needs play a role.
This incident highlights the stark differences in healthcare affordability between nations, even as globalisation makes medicines and services increasingly interconnected.
